Zhejiang Nhu Co Ltd - Asset Resilience Ratio
Zhejiang Nhu Co Ltd (002001) has an Asset Resilience Ratio of 4.38% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 002001 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2024)
This chart shows how Zhejiang Nhu Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Nhu Co Ltd (002001) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Nhu Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002001 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.97 Billion | 4.38% |
| Total Liquid Assets | CN¥1.97 Billion | 4.38% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Nhu Co Ltd maintains only 4.38% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Nhu Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Nhu Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Yabao Pharmaceutical Group Co Ltd
SHG:600351 |
Drug Manufacturers - Specialty & Generic | 0.27% |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 6.43% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 6.40% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Annual Asset Resilience Ratio for Zhejiang Nhu Co Ltd (2003–2024)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Nhu Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | CN¥745.82K ≈ $109.14K |
CN¥42.99 Billion ≈ $6.29 Billion |
-0.44pp |
| 2023-12-31 | 0.44% | CN¥173.06 Million ≈ $25.32 Million |
CN¥39.16 Billion ≈ $5.73 Billion |
-1.44pp |
| 2022-12-31 | 1.88% | CN¥720.31 Million ≈ $105.40 Million |
CN¥38.27 Billion ≈ $5.60 Billion |
-1.72pp |
| 2021-12-31 | 3.61% | CN¥1.25 Billion ≈ $183.02 Million |
CN¥34.69 Billion ≈ $5.08 Billion |
+0.85pp |
| 2020-12-31 | 2.76% | CN¥852.23 Million ≈ $124.71 Million |
CN¥30.90 Billion ≈ $4.52 Billion |
-2.15pp |
| 2019-12-31 | 4.91% | CN¥1.40 Billion ≈ $204.86 Million |
CN¥28.50 Billion ≈ $4.17 Billion |
-12.64pp |
| 2018-12-31 | 17.55% | CN¥3.85 Billion ≈ $563.38 Million |
CN¥21.93 Billion ≈ $3.21 Billion |
+15.63pp |
| 2017-12-31 | 1.92% | CN¥350.00 Million ≈ $51.22 Million |
CN¥18.18 Billion ≈ $2.66 Billion |
+1.92pp |
| 2016-12-31 | 0.00% | CN¥95.56K ≈ $13.98K |
CN¥11.41 Billion ≈ $1.67 Billion |
-0.01pp |
| 2015-12-31 | 0.01% | CN¥1.26 Million ≈ $183.77K |
CN¥9.72 Billion ≈ $1.42 Billion |
-1.96pp |
| 2014-12-31 | 1.97% | CN¥180.00 Million ≈ $26.34 Million |
CN¥9.12 Billion ≈ $1.34 Billion |
+1.93pp |
| 2013-12-31 | 0.04% | CN¥3.65 Million ≈ $534.81K |
CN¥8.56 Billion ≈ $1.25 Billion |
+0.01pp |
| 2012-12-31 | 0.03% | CN¥2.42 Million ≈ $354.27K |
CN¥7.84 Billion ≈ $1.15 Billion |
+0.03pp |
| 2011-12-31 | 0.01% | CN¥390.56K ≈ $57.15K |
CN¥7.15 Billion ≈ $1.05 Billion |
-0.03pp |
| 2010-12-31 | 0.03% | CN¥2.00 Million ≈ $292.07K |
CN¥6.15 Billion ≈ $900.40 Million |
+0.03pp |
| 2009-12-31 | 0.01% | CN¥268.30K ≈ $39.26K |
CN¥4.21 Billion ≈ $616.02 Million |
0.00pp |
| 2003-12-31 | 0.01% | CN¥100.00K ≈ $14.63K |
CN¥1.05 Billion ≈ $153.86 Million |
-- |
About Zhejiang Nhu Co Ltd
Zhejiang NHU Company Ltd. engages in the production and sale of nutrition, flavor and fragrance, and new polymer materials in the People's Republic of China. The company offers nutrition products, such as vitamin E, vitamin H, vitamin A, vitamin C, methionine, vitamin D3, biotin, coenzyme Q10, carotenoids, vitamin B5, vitamin B6, vitamin B12, serine, cystine, tryptophan, etc. for use in feed addi… Read more